據歐盟食品安全局（EFSA）消息，2023年10月31日，歐盟食品安全局就活性物質精甲霜靈（metalaxyl-M）的農藥風險評估發布同行評審。
經過評估，將精甲霜靈作為殺菌劑用在向日葵和菠菜種子的基礎上，歐盟食品安全局提出了適用于監管風險評估的可靠端點，列出了監管框架要求的缺失信息，發現問題時會進行報告。部分原文報道如下：
The conclusions of the EFSA following the peer review of the initial risk assessments carried out by the competent authorities of the rapporteur Member State, Belgium, and co-rapporteur Member State, Greece, for the pesticide active substance metalaxyl-M are reported. The context of the peer review was that required by Regulation (EC) No 1107/2009 of the European Parliament and of the Council. The conclusions were reached on the basis of the evaluation of the representative uses for the amendment to the conditions of approval of metalaxyl-M as a fungicide seed treatment for sunflower and spinach seeds intended to be sown in field and on the basis of data submitted to update the specified level of an impurity in the technical active substance. The reliable endpoints, appropriate for use in regulatory risk assessment are presented. Missing information identified as being required by the regulatory framework is listed. Concerns are reported where identified.
經過評估，將精甲霜靈作為殺菌劑用在向日葵和菠菜種子的基礎上，歐盟食品安全局提出了適用于監管風險評估的可靠端點，列出了監管框架要求的缺失信息，發現問題時會進行報告。部分原文報道如下：
The conclusions of the EFSA following the peer review of the initial risk assessments carried out by the competent authorities of the rapporteur Member State, Belgium, and co-rapporteur Member State, Greece, for the pesticide active substance metalaxyl-M are reported. The context of the peer review was that required by Regulation (EC) No 1107/2009 of the European Parliament and of the Council. The conclusions were reached on the basis of the evaluation of the representative uses for the amendment to the conditions of approval of metalaxyl-M as a fungicide seed treatment for sunflower and spinach seeds intended to be sown in field and on the basis of data submitted to update the specified level of an impurity in the technical active substance. The reliable endpoints, appropriate for use in regulatory risk assessment are presented. Missing information identified as being required by the regulatory framework is listed. Concerns are reported where identified.
